Israel Englander Cytosorbents Corp Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cytosorbents Corp stock. As of the latest transaction made, Millennium Management LLC holds 33,280 shares of CTSO stock, worth $34,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,280

Holding current value

$34,278

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.74 - $1.35 $24,627 - $44,928	33,280 New	33,280 $29,000
Q2 2024 Aug 14, 2024	SELL	$0.7 - $1.01 $11,131 - $16,061	-15,902 Reduced 44.37%	19,941 $13,000
Q1 2024 May 15, 2024	SELL	$0.86 - $1.07 $7,985 - $9,934	-9,285 Reduced 20.57%	35,843 $34,000
Q4 2023 Feb 14, 2024	SELL	$1.08 - $1.94 $154,721 - $277,926	-143,261 Reduced 76.05%	45,128 $50,000
Q2 2023 Aug 14, 2023	SELL	$2.37 - $3.65 $24,074 - $37,076	-10,158 Reduced 5.12%	188,389 $676,000
Q1 2023 May 15, 2023	SELL	$1.79 - $4.17 $41,084 - $95,709	-22,952 Reduced 10.36%	198,547 $669,000
Q4 2022 Feb 14, 2023	SELL	$1.03 - $2.03 $40,984 - $80,775	-39,791 Reduced 15.23%	221,499 $343,000
Q3 2022 Nov 14, 2022	SELL	$1.2 - $2.46 $316,045 - $647,892	-263,371 Reduced 50.2%	261,290 $355,000
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.22 $923,403 - $1.69 Million	524,661 New	524,661 $1.15 Million
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $87,883 - $129,078	-30,515 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $48,579 - $97,279	-11,995 Reduced 28.22%	30,515 $128,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $68,159 - $94,546	-9,737 Reduced 18.64%	42,510 $345,000
Q2 2021 Aug 16, 2021	BUY	$7.55 - $9.42 $394,464 - $492,166	52,247 New	52,247 $394,000
Q4 2020 Feb 16, 2021	SELL	$7.65 - $8.98 $1 Million - $1.18 Million	-130,937 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $965,005 - $1.51 Million	130,937 New	130,937 $1.04 Million
Q2 2020 Aug 14, 2020	SELL	$6.28 - $10.59 $285,545 - $481,516	-45,469 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$3.77 - $7.73 $171,418 - $351,475	45,469 New	45,469 $351,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $581,509 - $764,213	-98,228 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$6.82 - $8.56 $669,914 - $840,831	98,228 New	98,228 $744,000
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $481,285 - $650,504	-43,953 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$6.9 - $12.35 $2.35 Million - $4.2 Million	-340,377 Reduced 88.56%	43,953 $501,000
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $1.44 Million - $1.81 Million	220,353 Added 134.38%	384,330 $2.71 Million
Q4 2017 Feb 14, 2018	BUY	$5.9 - $7.05 $724,284 - $865,458	122,760 Added 297.84%	163,977 $1.07 Million
Q3 2017 Nov 14, 2017	BUY	$4.5 - $6.2 $185,476 - $255,545	41,217	41,217 $256,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

15.7M

Call Options Held

16K

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $44.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account